Technology
Ozempic shortage continues, forcing greater regulation for patients
The national medicine regulator has introduced restrictions on the prescription of diabetes drug Ozempic to help manage an international shortage.
Danish company Novo Nordisk advised the Therapeutic Goods Administration that supply of the drug through the rest of 2023 and 2024 will be limited, following increased demand of the low dose (0.25/0.5 mg) version recently.
The shortage has been linked to a social media trend in which people use it as a weight loss tool.
Catch the best deals and products hand-picked by our team at Best Picks >>
The TGA has blamed the shortage on “off-label prescribing”, where the drug is being advised for uses other than those approved in Australia.
“Making Ozempic involves a complex process to produce semaglutide using specialised equipment in a unique manufacturing setting,” the TGA advised on its website.
“Novo Nordisk advised that very limited new supplies of Ozempic 0.25/0.5 mg would be available before the end of 2023 and there would be intermittent supply of all strengths of Ozempic throughout 2024,” the TGA said.
The Therapeutic Goods Administration said to manage short supply, it has introduced a number of restrictions on the prescription of Ozempic, including recommending doctors only prescribe it to new patients if no other alternative was available.
Doctors are also being recommended to switch patients who are already using the drug to alternatives because continuous supply cannot be guaranteed.
TGA says Ozempic supplies “should be conserved for patients who are stabilised on Ozempic who have no other treatment options”.
Patients who currently use Ozempic for type 2 diabetes are being advised to check with their local pharmacy about supply.
Pharmacists are also being advised to continue prioritising limited supplies of Ozempic to patients stabilised on the treatment.
-
Technology7h ago
Elon Musk visits China as Tesla seeks self-driving technology rollout
-
Technology7h ago
Scientists find untapped pharmaceutical resources in deep sea
-
Technology19h ago
China prepares to launch Chang'e-6 lunar probe
-
Technology19h ago
Three more Chinese astronauts enter space station
-
Technology1d ago
Limited resources or be your own boss: Why GEN Z is not interested in job?
-
Technology1d ago
TikTok general counsel to move to new role focused on fighting US sale
-
Technology1d ago
How To Use The Meta AI Chatbot In Instagram, WhatsApp Along With Its Hidden Features
-
Technology1d ago
Chipmaker Intel falls as AI competition hurts forecast